Our findings demonstrate a key role of SphK2 in the pathology of CS-mediated COPD by impairing CFTR function, which represents an effective therapeutic strategy against COPD through inhibition of S1P signaling. The gene discussed is SPHK2; the disease is chronic obstructive pulmonary disease.